Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Is It Time for a New Approach to the Initial Treatment of Hypertension?

Is It Time for a New Approach to the Initial Treatment of Hypertension? COMMENTARY Is It Time for a New Approach to the Initial Treatment of Hypertension? ESULTS OF recent tri- ommendations, based on available (VHAS) compared verapamil SR als in the manage- outcome evidence, seemed reason- with a diuretic and reported no dif- ment of hypertension able at the time. ference in morbidity and mortality indicate that an up- Since 1997, results of long- outcomes between the groups; blood R date of recommenda- term comparative studies of b- pressure lowering was equivalent. tions for initial therapy may be indi- blocker/diuretic-based treatment In the United Kingdom Pro- 1-9 cated. programs or studies with other medi- spective Diabetes Study (UKPDS), in In 1997, the Sixth Report of the cations, angiotensin-converting en- which more than 1100 hyperten- Joint National Committee on Pre- zyme inhibitors (ACEIs), and CCBs sive patients with type 2 diabetes 1-9 vention, Detection, Evaluation, and have been published. The 3 ques- were evaluated during an 8 ⁄2-year Treatment of High Blood Pressure tions to be answered are as follows: period, an ACEI-based treatment (JNC-VI) recommended that di- 1. Is it blood pressure lower- group experienced the same mor- uretics or b-blockers be chosen as ing alone by any means that im- http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Internal Medicine American Medical Association

Is It Time for a New Approach to the Initial Treatment of Hypertension?

Moser, Marvin
JAMA Internal Medicine , Volume 161 (9) – May 14, 2001
Download PDF
5 pages

Loading next page...
 
/lp/american-medical-association/is-it-time-for-a-new-approach-to-the-initial-treatment-of-hypertension-bpeuqgzFhj

References (20)

Publisher
American Medical Association
Copyright
Copyright 2001 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
2168-6106
eISSN
2168-6114
DOI
10.1001/archinte.161.9.1140
Publisher site
See Article on Publisher Site

Abstract

COMMENTARY Is It Time for a New Approach to the Initial Treatment of Hypertension? ESULTS OF recent tri- ommendations, based on available (VHAS) compared verapamil SR als in the manage- outcome evidence, seemed reason- with a diuretic and reported no dif- ment of hypertension able at the time. ference in morbidity and mortality indicate that an up- Since 1997, results of long- outcomes between the groups; blood R date of recommenda- term comparative studies of b- pressure lowering was equivalent. tions for initial therapy may be indi- blocker/diuretic-based treatment In the United Kingdom Pro- 1-9 cated. programs or studies with other medi- spective Diabetes Study (UKPDS), in In 1997, the Sixth Report of the cations, angiotensin-converting en- which more than 1100 hyperten- Joint National Committee on Pre- zyme inhibitors (ACEIs), and CCBs sive patients with type 2 diabetes 1-9 vention, Detection, Evaluation, and have been published. The 3 ques- were evaluated during an 8 ⁄2-year Treatment of High Blood Pressure tions to be answered are as follows: period, an ACEI-based treatment (JNC-VI) recommended that di- 1. Is it blood pressure lower- group experienced the same mor- uretics or b-blockers be chosen as ing alone by any means that im-

Journal

JAMA Internal Medicine – American Medical Association

Published: May 14, 2001

There are no references for this article.